← Back to Search

Behavioural Intervention

Exercise for Marfan Syndrome

N/A
Recruiting
Led By Shaine A Morris, MD, MPH
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 10-25 years at enrollment
Male and female patients diagnosed with Marfan syndrome (defined by Ghent criteria and either a pathogenic variant in FBN1 or ectopia lentis)
Must not have
History of aortic surgery
Aortic dilation meeting threshold for prophylactic aortic surgical intervention (>/= 4.5 cm in diameter)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 2 weeks for 4 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effects of exercise in people with Marfan or Loeys-Dietz Syndrome, which affect the heart, bones, ligaments, and eyes. Exercise may have beneficial effects like improving strength, joint pain, and mood.

Who is the study for?
This trial is for young individuals aged 10-25 with Marfan syndrome, which affects the body's connective tissue. Participants must meet specific diagnostic criteria and cannot have had aortic or spinal surgery, major heart defects (except some conditions like mitral valve prolapse), conditions that limit moderate exercise, or an aorta wider than 4.5 cm.
What is being tested?
The study examines how safe and effective moderated dynamic exercise is for adolescents and young adults with Marfan Syndrome. It compares an exercise intervention group to a control group that does not receive this intervention.
What are the potential side effects?
While the trial primarily focuses on safety and effectiveness of moderate exercise in patients with Marfan Syndrome, potential side effects may include increased joint pain or cardiovascular stress due to physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 10 and 25 years old.
Select...
I have been diagnosed with Marfan syndrome.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had surgery on my aorta.
Select...
My aorta is enlarged to 4.5 cm or more, needing surgery.
Select...
I have had spinal surgery with implants that might affect MRI scans.
Select...
I cannot do moderate exercise due to my condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 2 weeks for 4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and every 2 weeks for 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Maximum VO2
Secondary study objectives
Aortic Root Distensibility
Aortic Root β-Stiffness index
Aortic pulse wave velocity from MRI
+24 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Exercise Intervention GroupExperimental Treatment1 Intervention
Group of up to 50 patients will randomly allocated into an experimental group at a 4:1 ratio intervention to controls. The experimental group will receive all of the preliminary outcome measure testing (cardiovascular, musculoskeletal, and psychological screening) in addition to exercise intervention education, demonstration, and follow up to ensure compliance and safety.
Group II: Control GroupExperimental Treatment1 Intervention
Control group will be randomly allocated at a 4:1 ratio, intervention to controls.. The control group will receive all of the preliminary outcome measure testing (cardiovascular, musculoskeletal, and psychological screening) and will be instructed to continue with baseline physical activities. They will be asked to return for a reassessment of all baseline procedures (cardiovascular, musculoskeletal, and psychological screening).

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,024 Previous Clinical Trials
6,029,445 Total Patients Enrolled
1 Trials studying Marfan Syndrome
23 Patients Enrolled for Marfan Syndrome
Southern Star Research Pty Ltd.Industry Sponsor
13 Previous Clinical Trials
572 Total Patients Enrolled
Shaine A Morris, MD, MPHPrincipal InvestigatorBaylor College of Medicine
2 Previous Clinical Trials
52 Total Patients Enrolled

Media Library

Exercise Intervention Group (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05809323 — N/A
Marfan Syndrome Research Study Groups: Control Group, Exercise Intervention Group
Marfan Syndrome Clinical Trial 2023: Exercise Intervention Group Highlights & Side Effects. Trial Name: NCT05809323 — N/A
Exercise Intervention Group (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05809323 — N/A
~16 spots leftby Jul 2025